ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Broad and Rockefeller settle CRISPR dispute

by Ryan Cross
January 22, 2018 | APPEARED IN VOLUME 96, ISSUE 4

The CRISPR patent dispute between the University of California, Berkeley, and Broad Institute of MIT & Harvard continues unabated, but a separate dispute between Broad and Rockefeller University has concluded. Rockefeller researcher Luciano Marraffini was an author on a foundational 2013 Science paper describing CRISPR gene editing along with Feng Zhang of Broad. Both scientists’ names were included on patents for using CRISPR in prokaryotes, but eukaryotic patents did not include Marraffini. Under a settlement between Broad and Rockefeller, the patents will remain unchanged.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment